Host-guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril

N.J. Wheate, V. Vora, N.G. Anthony, F.J. McInnes

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The potential use of cucurbit[7]uril (CB[7]) as an excipient in oral formulations for improved drug physical stability or for improved drug delivery was examined with the antituberculosis drugs pyrazinamide (pyrazine-2-carboxamide) and isoniazid (isonicotinohydrazide). Both drugs form 1:1 host-guest complexes with CB[7] as determined by H-1 nuclear magnetic resonance spectrometry, electrospray ionisation mass spectrometry and molecular modelling. Drug binding is stabilised by hydrophobic effects between the pyridine and pyrazine rings of isoniazid and pyrazinamide, respectively, to the inside cavity of the CB[7] macrocycle as well as hydrogen bonds between the hydrazide and amide groups of each drug to the CB[7] carbonyl portals. At pH 1.5, isoniazid binds CB[7] with a binding constant of 5.6 x 10(5) M-1, whilst pyrazinamide binds CB[7] at pH 7 with a much smaller binding constant (4.8 x 10(3) M-1). Finally, CB[7] prevents drug melting through encapsulation. Where previously pyrazinamide displays a typical melting point of 189 A degrees C and isoniazid 171 A degrees C, by differential scanning calorimetry, no melting or degradation at temperatures up to 280 A degrees C is observed for either drug once bound by CB[7].
LanguageEnglish
Pages359-367
Number of pages8
JournalJournal of Inclusion Phenomena and Macrocyclic Chemistry
Volume68
Issue number3-4
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Pyrazines
pyrazines
Cucurbitaceae
drugs
Pharmaceutical Preparations
Freezing
melting
Melting
hydrazides
Drug Stability
Electrospray ionization
Molecular modeling
Electrospray Ionization Mass Spectrometry
cucurbit(7)uril
Excipients
pyridines
Differential Scanning Calorimetry
melting point
encapsulation
amides

Keywords

  • tuberculosis
  • cucurbituril
  • pyrazinamide
  • isoniazid

Cite this

Wheate, N.J. ; Vora, V. ; Anthony, N.G. ; McInnes, F.J. / Host-guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril. In: Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2010 ; Vol. 68, No. 3-4. pp. 359-367 .
@article{1e4b831de41040928e21e936c2f91382,
title = "Host-guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril",
abstract = "The potential use of cucurbit[7]uril (CB[7]) as an excipient in oral formulations for improved drug physical stability or for improved drug delivery was examined with the antituberculosis drugs pyrazinamide (pyrazine-2-carboxamide) and isoniazid (isonicotinohydrazide). Both drugs form 1:1 host-guest complexes with CB[7] as determined by H-1 nuclear magnetic resonance spectrometry, electrospray ionisation mass spectrometry and molecular modelling. Drug binding is stabilised by hydrophobic effects between the pyridine and pyrazine rings of isoniazid and pyrazinamide, respectively, to the inside cavity of the CB[7] macrocycle as well as hydrogen bonds between the hydrazide and amide groups of each drug to the CB[7] carbonyl portals. At pH 1.5, isoniazid binds CB[7] with a binding constant of 5.6 x 10(5) M-1, whilst pyrazinamide binds CB[7] at pH 7 with a much smaller binding constant (4.8 x 10(3) M-1). Finally, CB[7] prevents drug melting through encapsulation. Where previously pyrazinamide displays a typical melting point of 189 A degrees C and isoniazid 171 A degrees C, by differential scanning calorimetry, no melting or degradation at temperatures up to 280 A degrees C is observed for either drug once bound by CB[7].",
keywords = "tuberculosis, cucurbituril , pyrazinamide, isoniazid",
author = "N.J. Wheate and V. Vora and N.G. Anthony and F.J. McInnes",
year = "2010",
month = "12",
doi = "10.1007/s10847-010-9795-3",
language = "English",
volume = "68",
pages = "359--367",
journal = "Journal of Inclusion Phenomena and Macrocyclic Chemistry",
issn = "0923-0750",
number = "3-4",

}

Host-guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril. / Wheate, N.J.; Vora, V.; Anthony, N.G.; McInnes, F.J.

In: Journal of Inclusion Phenomena and Macrocyclic Chemistry, Vol. 68, No. 3-4, 12.2010, p. 359-367 .

Research output: Contribution to journalArticle

TY - JOUR

T1 - Host-guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril

AU - Wheate, N.J.

AU - Vora, V.

AU - Anthony, N.G.

AU - McInnes, F.J.

PY - 2010/12

Y1 - 2010/12

N2 - The potential use of cucurbit[7]uril (CB[7]) as an excipient in oral formulations for improved drug physical stability or for improved drug delivery was examined with the antituberculosis drugs pyrazinamide (pyrazine-2-carboxamide) and isoniazid (isonicotinohydrazide). Both drugs form 1:1 host-guest complexes with CB[7] as determined by H-1 nuclear magnetic resonance spectrometry, electrospray ionisation mass spectrometry and molecular modelling. Drug binding is stabilised by hydrophobic effects between the pyridine and pyrazine rings of isoniazid and pyrazinamide, respectively, to the inside cavity of the CB[7] macrocycle as well as hydrogen bonds between the hydrazide and amide groups of each drug to the CB[7] carbonyl portals. At pH 1.5, isoniazid binds CB[7] with a binding constant of 5.6 x 10(5) M-1, whilst pyrazinamide binds CB[7] at pH 7 with a much smaller binding constant (4.8 x 10(3) M-1). Finally, CB[7] prevents drug melting through encapsulation. Where previously pyrazinamide displays a typical melting point of 189 A degrees C and isoniazid 171 A degrees C, by differential scanning calorimetry, no melting or degradation at temperatures up to 280 A degrees C is observed for either drug once bound by CB[7].

AB - The potential use of cucurbit[7]uril (CB[7]) as an excipient in oral formulations for improved drug physical stability or for improved drug delivery was examined with the antituberculosis drugs pyrazinamide (pyrazine-2-carboxamide) and isoniazid (isonicotinohydrazide). Both drugs form 1:1 host-guest complexes with CB[7] as determined by H-1 nuclear magnetic resonance spectrometry, electrospray ionisation mass spectrometry and molecular modelling. Drug binding is stabilised by hydrophobic effects between the pyridine and pyrazine rings of isoniazid and pyrazinamide, respectively, to the inside cavity of the CB[7] macrocycle as well as hydrogen bonds between the hydrazide and amide groups of each drug to the CB[7] carbonyl portals. At pH 1.5, isoniazid binds CB[7] with a binding constant of 5.6 x 10(5) M-1, whilst pyrazinamide binds CB[7] at pH 7 with a much smaller binding constant (4.8 x 10(3) M-1). Finally, CB[7] prevents drug melting through encapsulation. Where previously pyrazinamide displays a typical melting point of 189 A degrees C and isoniazid 171 A degrees C, by differential scanning calorimetry, no melting or degradation at temperatures up to 280 A degrees C is observed for either drug once bound by CB[7].

KW - tuberculosis

KW - cucurbituril

KW - pyrazinamide

KW - isoniazid

UR - http://www.scopus.com/inward/record.url?scp=78649446693&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1007/s10847-010-9795-3

U2 - 10.1007/s10847-010-9795-3

DO - 10.1007/s10847-010-9795-3

M3 - Article

VL - 68

SP - 359

EP - 367

JO - Journal of Inclusion Phenomena and Macrocyclic Chemistry

T2 - Journal of Inclusion Phenomena and Macrocyclic Chemistry

JF - Journal of Inclusion Phenomena and Macrocyclic Chemistry

SN - 0923-0750

IS - 3-4

ER -